Adverse drug reaction profile of prophylactic hydroxychloroquine for COVID-19 among doctors

Adverse drug reaction profile of prophylactic hydroxychloroquine for COVID-19 among doctors

Background: Recently, hydroxychloroquine (HCQ) has been advocated by the Indian Council of Medical Research for prophylaxis of COVID-19, and the Food and Drug Administration has given emergency use authorization for its use in the treatment of severe COVID-19 disease in hospitalized patients. HCQ is...

Full description

Bibliographic Details
Main Authors: Rajesh K Kulkarni, Aarti A Kinikar, Tushar Jadhav
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Medical Journal of Dr. D.Y. Patil Vidyapeeth
Subjects:
adverse drug effects
chemoprophylaxis
covid-19
doctors
hydroxychloroquine
Online Access:http://www.mjdrdypv.org/article.asp?issn=2589-8302;year=2020;volume=13;issue=3;spage=204;epage=207;aulast=Kulkarni

Internet

http://www.mjdrdypv.org/article.asp?issn=2589-8302;year=2020;volume=13;issue=3;spage=204;epage=207;aulast=Kulkarni

Similar Items